Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials Biotech Investing
Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector Pharmaceutical Investing
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201 Biotech Investing
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection Pharmaceutical Investing
Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo Pharmaceutical Investing
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel Genetics Investing
